Table 2 Implementation Phases I and II overview
Evaluation aim | Evaluation activities |
|---|---|
Phase 1: randomized trial, implementation and sustainment | |
Needs assessment (AT1; Fig. 1, Box 1) | Engage in the baseline mixed methods needs assessment |
(a) A subset of clinicians (N = 5–8) identified via purposive sampling representing extreme variation will participate in a 1.5-h focus group | |
(i) Rapid Ethnography will then be used to uncover site-specific insights that will guide the content of training and consultation in the tailored condition only | |
(b) All enrolled clinicians will complete the battery of baseline measures (Table 3) | |
Implementation teams form | |
(a) Opinion leaders (Childers, 1986) and self-nominated MBC champions will be identified from the needs assessment | |
Clinicians Participate in 4-h MBC training workshop | |
Implementation teams convene triweekly and optional consultation offered to participating clinicians | |
(a) Implementation team meetings and consultation sessions will be audio-recorded and coded (see Additional file 1). | |
(b) A site-specific team member will also log meetings (using Additional file 1) and the data will be triangulated to evaluate consistency across sites | |
Implementation/process evaluation (AT2; Fig. 1, Box 2) | Engage in mixed methods reassessment |
(a) Conduct an additional round of focus groups with clinicians | |
(b) Re-administer the baseline surveys to clinicians | |
Site implementation teams encouraged to continue to meet to promote MBC sustainment without the research personnel present | |
Outcome/impact evaluation (AT3; Fig. 1, Box 3) | Engage in mixed methods reassessment |
(a) Conduct an additional round of focus groups with clinicians | |
(b) Re-administer the baseline surveys to clinicians | |
Conduct focus groups with implementation team to review their experience and site progress since the research personnel exited the team. | |
Phase 2: post hoc characterization of MBC fidelity | |
Outcome/impact evaluation | Measure MBC fidelity via data collected in the electronic health record |
(a) Clinician reported client PHQ-9 scores | |
(b) A report to indicate whether the clinician looked at the scores | |
(c) Clinician self-report of whether they discussed the PHQ-9 scores with the client | |
Triangulate MBC fidelity outcome with client post-session text message surveys and objective therapy session coding | |
Focus group data formally coded for mixed method analysis | |